Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2007.089011v1, 2007; 10.1373/clinchem.2007.089011
This Article
Right arrow Full Text (PDF)
Right arrow 089011.Supplemental Data
Right arrow All Versions of this Article:
clinchem.2007.089011v1
53/12/2169    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wikoff, W. R.
Right arrow Articles by Siuzdak, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wikoff, W. R.
Right arrow Articles by Siuzdak, G.

Received on April 12, 2007
Accepted on October 2, 2007

Automation and Analytical Techniques

Metabolomics Identifies Perturbations in Human Disorders of Propionate Metabolism

William R. Wikoff 1, Jon A. Gangoiti 2, Bruce A. Barshop 2*, Gary Siuzdak 1*

1 Department of Molecular Biology and The Center for Mass Spectrometry, The Scripps Research Institute, La Jolla, CA
2 Department of Pediatrics, University of California–San Diego, School of Medicine, La Jolla, CA

* To whom correspondence should be addressed. E-mail: bbarshop{at}ucsd.edu.

Background: We applied untargeted mass spectrometry-based metabolomics to the diseases methylmalonic acidemia (MMA) and propionic acidemia (PA).

Methods: We used a screening platform that used untargeted, mass-based metabolomics of methanol-extracted plasma to find significantly different molecular features in human plasma samples from MMA and PA patients and from healthy individuals. Capillary reversed-phase liquid chromatography (4 µL/min) was interfaced to a TOF mass spectrometer, and data were processed using nonlinear alignment software (XCMS) and an online database (METLIN) to find and identify metabolites differentially regulated in disease.

Results: Of the approximately 3500 features measured, propionyl carnitine was easily identified as the best biomarker of disease (P value 1.3 x 10-18), demonstrating the proof-of-concept use of untargeted metabolomics in clinical chemistry discovery. Five additional acylcarnitine metabolites showed significant differentiation between plasma from patients and healthy individuals, and {gamma}-butyrobetaine was highly increased in a subset of patients. Two acylcarnitine metabolites and numerous unidentified species differentiate MMA and PA. Many metabolites that do not appear in any public database, and that remain unidentified, varied significantly between normal, MMA, and PA, underscoring the complex downstream metabolic effects resulting from the defect in a single enzyme.

Conclusions: This proof-of-concept study demonstrates that metabolomics can expand the range of metabolites associated with human disease and shows that this method may be useful for disease diagnosis and patient clinical evaluation.




The following articles in journals at HighWire Press have cited this article:


Home page
Physiol. GenomicsHome page
S. A. Eraly, V. Vallon, T. Rieg, J. A. Gangoiti, W. R. Wikoff, G. Siuzdak, B. A. Barshop, and S. K. Nigam
Multiple organic anion transporters contribute to net renal excretion of uric acid
Physiol Genomics, April 1, 2008; 33(2): 180 - 192.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. J. Bennett
Untargeted Metabolomic Analysis Hits the Target
Clin. Chem., December 1, 2007; 53(12): 2037 - 2039.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Association for Clinical Chemistry.